Streetbeat News

Regulatory

HUDA

Hudson Acquisition I Corp. (NASDAQ:HUDA) has received a notice from Nasdaq regarding late filings of its annual and quarterly reports, putting it out of compliance with Nasdaq Listing Rule 5250(c)(1).

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 8:50 pm

LUXH

LuxUrban Hotels received a notice of delisting or failure to satisfy a continued listing rule or standard from Nasdaq on June 11, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 8:23 pm

DKNG

DraftKings Inc. (NASDAQ:DKNG) shares surged by 7.81% on Monday following a U.S. Supreme Court decision that supports the Seminole Tribe's exclusive rights to online sports betting in Florida. Additionally, optimism about New Jersey's 2025 budget not including new taxes contributed to the positive sentiment.

Portfolio Pulse from Vaishali Prayag

June 17, 2024 | 8:23 pm

AWIN

Aerwins Technologies Inc. has appointed Kiran Sidhu as the interim CFO following the resignation of Yinshun He. Additionally, the company received a final delisting notice from the Nasdaq Hearings Panel.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 8:21 pm

CHNG

UNH

The Centers for Medicare & Medicaid Services (CMS) is preparing to close a program that addressed Medicare funding issues resulting from a cyber-attack on Change Healthcare. Payments under the Accelerated and Advance Payment Program for Change Healthcare/Optum payment disruption will conclude on July 12. After this date, CMS will no longer accept new applications for accelerated or advance payments under this program.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 8:19 pm

BNGO

Bionano Laboratories, a division of Bionano Genomics, Inc. (NASDAQ:BNGO), announced that the American Medical Association (AMA) has established a new Category I CPT code for the use of optical genome mapping (OGM) in hematological malignancy analysis. This code is expected to be included in the next CPT codebook and effective from January 1, 2025, facilitating reimbursement for the OGM-Dx™ HemeOne test.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 8:12 pm

ELWS

Earlyworks has regained compliance with Nasdaq's listing requirements, ensuring its continued presence on the exchange.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 8:10 pm

KYTX

Kyverna Therapeutics announced the first use of KYV-101, an anti-CD19 CAR T-cell product, in a patient with severe stiff-person syndrome. The treatment showed significant improvement in walking distance and a 40% reduction in GABAergic medications, with low-grade side effects. This supports further exploration of KYV-101 in neuroimmunological diseases.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 8:09 pm

VXRT

Vaxart has announced a business update, highlighting that it expects net proceeds from a $40 million offering and reimbursement under the Project NextGen Award of up to $453 million. This funding is expected to extend the company's cash runway into 2026, allowing it to focus on key clinical and regulatory milestones in its COVID-19 and norovirus programs.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 8:08 pm

PRCT

PROCEPT BioRobotics (NASDAQ:PRCT) announced that the AMA has established a new CPT Category I code for its Aquablation therapy to treat benign prostatic hyperplasia, effective January 1, 2026. This change reflects increased utilization and strong clinical outcomes.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 8:07 pm